These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18303084)

  • 1. Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension.
    Moreno-Vinasco L; Gomberg-Maitland M; Maitland ML; Desai AA; Singleton PA; Sammani S; Sam L; Liu Y; Husain AN; Lang RM; Ratain MJ; Lussier YA; Garcia JG
    Physiol Genomics; 2008 Apr; 33(2):278-91. PubMed ID: 18303084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor tyrosine kinase inhibitors in rodent pulmonary hypertension.
    Moreno-Vinasco L; Garcia JG
    Adv Exp Med Biol; 2010; 661():419-34. PubMed ID: 20204746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling.
    Klein M; Schermuly RT; Ellinghaus P; Milting H; Riedl B; Nikolova S; Pullamsetti SS; Weissmann N; Dony E; Savai R; Ghofrani HA; Grimminger F; Busch AE; Schäfer S
    Circulation; 2008 Nov; 118(20):2081-90. PubMed ID: 18955668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
    Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine kinase inhibitors are potent acute pulmonary vasodilators in rats.
    Abe K; Toba M; Alzoubi A; Koubsky K; Ito M; Ota H; Gairhe S; Gerthoffer WT; Fagan KA; McMurtry IF; Oka M
    Am J Respir Cell Mol Biol; 2011 Oct; 45(4):804-8. PubMed ID: 21378262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats.
    Leong ZP; Hikasa Y
    Vascul Pharmacol; 2018 Nov; 110():31-41. PubMed ID: 30071297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.
    Reiberger T; Angermayr B; Schwabl P; Rohr-Udilova N; Mitterhauser M; Gangl A; Peck-Radosavljevic M
    J Hepatol; 2009 Nov; 51(5):865-73. PubMed ID: 19726100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling.
    Kojonazarov B; Sydykov A; Pullamsetti SS; Luitel H; Dahal BK; Kosanovic D; Tian X; Majewski M; Baumann C; Evans S; Phillips P; Fairman D; Davie N; Wayman C; Kilty I; Weissmann N; Grimminger F; Seeger W; Ghofrani HA; Schermuly RT
    Int J Cardiol; 2013 Sep; 167(6):2630-7. PubMed ID: 22854298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line.
    Keswani RN; Chumsangsri A; Mustafi R; Delgado J; Cohen EE; Bissonnette M
    Dis Esophagus; 2008; 21(6):514-21. PubMed ID: 18840136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of rho-kinase inhibition on pulmonary hypertension, lung growth, and structure in neonatal rats chronically exposed to hypoxia.
    Ziino AJ; Ivanovska J; Belcastro R; Kantores C; Xu EZ; Lau M; McNamara PJ; Tanswell AK; Jankov RP
    Pediatr Res; 2010 Feb; 67(2):177-82. PubMed ID: 19858775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multikinase inhibitor sorafenib prevents pressure overload-induced left ventricular hypertrophy in rats by blocking the c-Raf/ERK1/2 signaling pathway.
    Daryadel A; Bogdanova A; Gassmann M; Mueller X; Zünd G; Seifert B; Lehalle C; Frossard N; Tavakoli R
    J Cardiothorac Surg; 2014 May; 9():81. PubMed ID: 24885948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAP kinase kinase kinase-2 (MEKK2) regulates hypertrophic remodeling of the right ventricle in hypoxia-induced pulmonary hypertension.
    Brown RD; Ambler SK; Li M; Sullivan TM; Henry LN; Crossno JT; Long CS; Garrington TP; Stenmark KR
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H269-81. PubMed ID: 23125215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytoprotective and antiangiogenic effects of the multikinase inhibitor sorafenib on human retinal pigmentepithelium].
    Kernt M; Thiele S; Hirneiss C; Neubauer AS; Lackerbauer CA; Wolf A; Eibl KH; Haritoglou C; Ulbig MW; Kampik A
    Ophthalmologe; 2011 May; 108(5):445-51. PubMed ID: 21253747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo.
    Wei G; Wang M; Hyslop T; Wang Z; Carr BI
    Int J Cancer; 2010 Dec; 127(12):2949-58. PubMed ID: 21351273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of the multikinase inhibitor sorafenib in combination with cytarabine in acute myeloid leukemia.
    Hu S; Niu H; Inaba H; Orwick S; Rose C; Panetta JC; Yang S; Pounds S; Fan Y; Calabrese C; Rehg JE; Campana D; Rubnitz JE; Baker SD
    J Natl Cancer Inst; 2011 Jun; 103(11):893-905. PubMed ID: 21487100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sorafenib on murine liver regeneration.
    Hora C; Romanque P; Dufour JF
    Hepatology; 2011 Feb; 53(2):577-86. PubMed ID: 21274878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis.
    Hennenberg M; Trebicka J; Stark C; Kohistani AZ; Heller J; Sauerbruch T
    Br J Pharmacol; 2009 May; 157(2):258-70. PubMed ID: 19338580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors.
    Morgillo F; Martinelli E; Troiani T; Orditura M; De Vita F; Ciardiello F
    PLoS One; 2011; 6(12):e28841. PubMed ID: 22174910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Src tyrosine kinases in experimental pulmonary hypertension.
    Pullamsetti SS; Berghausen EM; Dabral S; Tretyn A; Butrous E; Savai R; Butrous G; Dahal BK; Brandes RP; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Rosenkranz S; Schermuly RT
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1354-65. PubMed ID: 22516066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of sorafenib action in liver cancer cells.
    Cervello M; Bachvarov D; Lampiasi N; Cusimano A; Azzolina A; McCubrey JA; Montalto G
    Cell Cycle; 2012 Aug; 11(15):2843-55. PubMed ID: 22801548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.